Haemonetics Corp (New York Stock Exchange:HAE)
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Profitable, but on a thin margin.
- Revenue
- $1.35B
- Net income
- $96.3M
- Net margin
- 7.1%
Heavily indebted for what it earns.
- Total debt
- $1.17B
- Cash
- $223.4M
- Net debt / EBITDA
- 3.64x
Comfortably covers what is due within a year.
- Current assets
- $810.8M
- Current liabilities
- $263.2M
- Current ratio
- 3.08
The business funds itself from operations.
- Operating cash flow
- $328.1M
- Free cash flow
- $291.2M
- FCF margin
- 21.5%
Not funding itself by issuing shares.
- Shares outstanding
- 45.4M
- Share growth (1y)
- -5.7%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
HAE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 27, 2026 | Mar 28, 2026 | Dec 27, 2025 | Sep 27, 2025 | Jun 28, 2025 | Mar 31, 2025 |
| Revenue | 339.38 M | 346.35 M | 338.97 M | 327.31 M | 321.39 M | 330.60 M |
| Revenue Growth (YoY) | 5.60 % | 4.76 % | -2.75 % | -5.27 % | -4.40 % | -3.70 % |
| Cost of Revenue | 136.58 M | 148.14 M | 147.56 M | 143.89 M | 129.53 M | 148.68 M |
| Gross Profit | 202.80 M | 198.21 M | 191.41 M | 183.42 M | 191.86 M | 181.92 M |
| SG&A Expense | 118.94 M | 121.83 M | 107.56 M | 101.62 M | 0.00 | 114.50 M |
| R&D Expense | 16.20 M | 14.45 M | 14.29 M | 14.52 M | 16.26 M | 15.96 M |
| Operating Expenses | 145.34 M | 146.76 M | 121.85 M | 116.14 M | 137.99 M | 130.46 M |
| Operating Income | 57.46 M | 51.45 M | 69.56 M | 67.28 M | 53.87 M | 51.46 M |
| Pretax Income | 47.57 M | -28.40 M | 59.98 M | 51.28 M | 45.17 M | 70.74 M |
| Tax Provision | 14.56 M | -8.25 M | 15.23 M | 12.60 M | 11.14 M | 12.76 M |
| Net Income | 33.01 M | -20.15 M | 44.74 M | 38.68 M | 34.03 M | 57.98 M |
| EPS (Basic) | 0.73 | -0.44 | 0.96 | 0.81 | 0.71 | 1.17 |
| EPS (Diluted) | 0.72 | -0.44 | 0.95 | 0.81 | 0.70 | 1.17 |
| Shares Outstanding | 45.36 M | 46.22 M | 46.79 M | 47.59 M | 48.11 M | 49.19 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.